Sak and colleagues [58] showed that inhibition of AURKB with low AZD1152-hydroxyquinazoline pyrazol anilide (AZD 1152-HQPA) concentrations concomitant to radiotherapy negatively affects repopulation of NSCLC cell lines, indicating the combined efficacy of AURKB inhibition and irradiation in regrowth of lung cancer cells. Here, AURKB is linked to non-small cell lung carcinoma.